enVVeno Medical Corp is a medical device company focused on the development of bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
NVNO is expected to report earnings to fall 5.71% to -33 cents per share on November 29
Q3'24
Est.
$-0.33
Q4'24
Est.
$-0.35
Q2'24
Beat
by $0.05
Q1'24
Beat
by $0.09
Q4'23
Beat
by $0.22
The last earnings report on February 27 showed earnings per share of -34 cents, meeting the estimate of -34 cents. With 94.39K shares outstanding, the current market capitalization sits at 72.44M.